Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 6Neoplasms 3Lung Neoplasms 3Uterine Cervical Neoplasms 2Smoking Cessation 2Prostatic Neoplasms 2Communication 2Colorectal Neoplasms 2Uveal Melanoma 1Triple Negative Breast Neoplasms 1Tobacco Use Cessation 1Thyroid Neoplasms 1Sexual Dysfunction, Physiological 1Rectal Neoplasms 1Patient Preference 1Patient Acceptance of Health Care 1Papillary Thyroid Microcarcinoma 1Melanoma 1Lung Cancer Screening 1Hematologic Neoplasms 1Health Behavior 1Glioblastoma 1Gastrointestinal Neoplasms 1Endometrial Neoplasms 1Cancer Prevention 1Cancer Pain 1Brain Neoplasms 1Attitude to Health 1

Interventions

palbociclib 1exemestane 1delta 24-sterol reductase 1Vinorelbine 1Tamoxifen 1Risk Assessment 1Paclitaxel 1Letrozole 1Influenza Vaccines 1Fulvestrant 1Focus Groups 1Epirubicin 1Drug Therapy 1Counseling 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Patient Acceptance of Health Care × Focus Groups × Clear all
NCT06559462 2025-11-25

DPYD Nudges

Abramson Cancer Center at Penn Medicine

Phase NA Completed
50 enrolled
Gastrointestinal

Gastrointestinal Neoplasms, Patient Acceptance of Health Care

Data powered by HemOnc (CC BY 4.0) Colophon âš¡